Eric Kampmann

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

A randomized clinical study comparing trabectedin combined with regional hyperthermia with trabectedin in patients with advanced soft tissue sarcoma: HyperTET, a German Interdisciplinary Sarcoma Group trial.

A randomized clinical study comparing trabectedin combined with regional hyperthermia with trabectedin in patients with advanced soft tissue sarcoma: HyperTET, a German Interdisciplinary Sarcoma Group trial.

Journal: ESMO open
Published: August 27, 2025

VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?

VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?

Journal: Cancers
Published: January 18, 2022

Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma.

Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma.

Journal: Cancers
Published: October 13, 2020

Structured reporting has the potential to reduce reporting times of dual-energy x-ray absorptiometry exams.

Structured reporting has the potential to reduce reporting times of dual-energy x-ray absorptiometry exams.

Journal: BMC musculoskeletal disorders
Published: February 03, 2020

A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas.

A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas.

Journal: Cancer immunology, immunotherapy : CII
Published: November 05, 2019

Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma.

Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma.

Journal: Sarcoma
Published: September 01, 2019

Hallmarks of hyperthermia in driving the future of clinical hyperthermia as targeted therapy: translation into clinical application.

Hallmarks of hyperthermia in driving the future of clinical hyperthermia as targeted therapy: translation into clinical application.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: January 26, 2016

Neoadjuvant or adjuvant sirolimus for malignant metastatic or locally advanced perivascular epithelioid cell tumors: two case reports.

Neoadjuvant or adjuvant sirolimus for malignant metastatic or locally advanced perivascular epithelioid cell tumors: two case reports.

Journal: Anti-cancer drugs
Published: December 10, 2015

Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repair.

Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repair.

Journal: International journal of cancer
Published: September 22, 2015

VEGFR2 predicts decreased patients survival in soft tissue sarcomas.

VEGFR2 predicts decreased patients survival in soft tissue sarcomas.

Journal: Pathology, research and practice
Published: January 28, 2015

Tyrosine kinases in soft tissue tumors

Tyrosine kinases in soft tissue tumors

Journal: Der Pathologe
Published: September 07, 2014

Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.

Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.

Journal: Journal of clinical pathology
Published: April 22, 2014
Showing 1-12 of 14

Last Updated: 09/26/2026